Bruce Levine, PhD, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, highlights the presentations being covered in the ‘Advances and emerging technologies in immune-mediated cancer treatments’ session at the International Society for Cellular Therapy (ISCT) 2020 meeting.
This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).